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A B S T R A C T
Carbon monoxide (CO) is a gasotransmitter endogenously produced by the activity of heme oxygenase, which is
a stress-response enzyme. Endogenous CO or low concentrations of exogenous CO have been described to present
several cytoprotective functions: anti-apoptosis, anti-inflammatory, vasomodulation, maintenance of home-
ostasis, stimulation of preconditioning and modulation of cell differentiation. The present review revises and
discuss how CO regulates cell metabolism and how it is involved in the distinct cytoprotective roles of CO. The
first found metabolic effect of CO was its increase on cellular ATP production, and since then much data have
been generated. Mitochondria are the most described and studied cellular targets of CO. Mitochondria exposure
to this gasotransmitter leads several consequences: ROS generation, stimulation of mitochondrial biogenesis,
increased oxidative phosphorylation or mild uncoupling effect. Likewise, CO negatively regulates glycolysis and
improves pentose phosphate pathway. More recently, CO has also been disclosed as a regulating molecule for
metabolic diseases, such as obesity and diabetes with promising results.
1. Introduction
Carbon monoxide (CO) was first described to be endogenously
produced in 1949, when it was found in exhaled human breath [1].
Only 20 years later, the enzyme responsible for CO production was
identified. Tenhunen and colleagues have discovered that heme de-
gradation by microsomal heme oxygenase (HO) originates CO, iron
(Fe2+) and biliverdin [2]. In fact, HO catalyzes the first and limiting
rate step of heme oxidative degradation by opening Fe-protoporphyrin-
IX ring into free Fe2+, CO and biliverdin, whose reaction consumes O2
and NADPH as electrons donor [3]. HO activity is cytoprotective for
two main reasons: (i) it eliminates free heme, which is potentially very
toxic, and (ii) its products present beneficial properties. First, biliverdin
is rapidly converted by biliverdin reductase into bilirubin, which is a
potent anti-oxidant [4]. Second, iron binds to iron regulatory proteins
(IRP) increasing ferritin expression, which promotes cytoprotection [5].
Finally, CO emerges as a gasotransmitter with several beneficial bio-
logical functions revised in Refs. [6–10], namely maintenance of tissue
homeostasis, anti-inflammation, cytoprotection, cardioprotection,
promotion of preconditioning and tolerance state, regulation of cell
differentiation/proliferation and modulation of cell metabolism. The
present review tackles how endogenous CO or low concentrations of
exogenous CO modulate cell metabolism in different cells and tissues,
and discusses CO's potential impact on human health.
2. Carbon monoxide releasing molecules (CORM)
The development of carbon monoxide releasing molecules (CORM)
emerges due to the potential application of this gasotransmitter as a
therapeutic agent in Medicine. The use of CO gas presents intrinsic
limitations because of its great affinity to hemoglobin, forming car-
boxyhemoglobin and hampering optimal oxygen delivery. Therefore,
the development of strategies to deliver CO in a safer mode is needed.
CORMs are metal or transition metal carbonyl complexes that function
as a prodrug to deliver CO under temporal and spatial controlled con-
ditions [11,12]. In fact, CORM design must take into account water
solubility, biocompatibility, toxicity, absorption, distribution, metabo-
lism and excretion properties [11]. Herein four different types of
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CORMs are discussed as modulators of cell metabolism. CORM-2 and
CORM-3 contain a ruthenium center and release CO with t1/2 of 1 min
[13,14]. While CORM-2 is soluble in DMSO, CORM-3 is water soluble
and only slightly increases carboxyhemoglobin levels when injected in
vivo, which is a great advantage [15]. CORM-A1 has boron in its center
and releases CO in a pH- and temperature-dependent manner with t1/2
of 21 min, being a slow releaser [16]. Of note, CORM biological effect
might be also dependent on CO release kinetics. Finally, CORM-401
presents a manganese center, is water soluble and provides at least
3 mol of CO per mole of compound [17]. Moreover, CORM-401 is re-
latively stable in PBS buffer, and 1 mM of CORM-401 releases 0.33 mol
equivalent of CO gas in 4 h [17]. In biological systems, CORM-3 and
CORM-A1 are the most studied with well-established functions of va-
sodilation, anti-inflammation and cytoprotection.
3. ATP assessment following CO treatment
The first clues about the CO's potential modulation of cell metabo-
lism emerged in 2004 when Lavitrano and colleagues have found an
improved cardiac metabolic status in CO-treated pigs before ischemia
and reperfusion injury [18]. In fact, pre-treatment with CO gas
(250 ppm) increased heart levels of ATP and phosphocreatine, which is
a high-energy phosphate cellular reserve. Likewise, in hepatocytes,
endogenous CO derived from heme-oxygenase activity or exogenous CO
exposure increases ATP production that, in turn, activates p38 MAPK
signaling [19]. In vivo, CO gas exposure also increased ATP levels in
liver and in in vitro primary cultures of hepatocytes. These higher
concentrations of ATP are associated with higher viability of hepato-
cytes and mice in response to TNF-α treatment and fulminant hepatitis,
respectively [20]. The CO improvement of cellular energy metabolism
is dependent on soluble guanylyl cyclase [20]. Nevertheless, in both
models (heart and liver), CO-induced higher ATP levels can also be a
consequence of increased cell viability rather than an improvement of
cellular metabolism. Only later, more accurate studies properly re-
vealed the role of CO in cell metabolism regulation, which is discussed
below.
4. CO acts via mitochondrial ROS signaling
Several studies have demonstrated that many CO's biological ben-
eficial effects are dependent on mitochondrial ROS generation, re-
viewed in Refs. [10,21,22]. In fact, CO-induced low levels of mi-
tochondrial ROS act as signaling molecules, as a preconditioning-like
effect, which in turn, promote different biological responses: cytopro-
tection, anti-inflammatory, modulation of cell metabolism or cellular
differentiation. In this section, the molecular mechanisms of mi-
tochondrial ROS generation are discussed. It is worth of note that for
ROS to signal and to exert beneficial properties, they must be at low
concentrations.
Despite all the described biological functions of CO, its pathways
and in particular, its molecular targets in biological systems are still a
matter of great debate. CO is a quite chemically inert molecule and it
binds to transition metals present in proteins [23,24]. In biological
systems, the typical target of CO are heme-containing proteins, namely
soluble guanylate cyclase, cytochromes, hemoglobin and myoglobin.
Notably, CO can only bind to reduced Fe2+, limiting the potential
target proteins, in contrast to NO that donates electrons to Fe3+ and
accepts electrons from Fe2+ [24].
High levels of CO are toxic and lead to tissue hypoxia at systemic
level and to mitochondrial damage at cellular level. In fact, cytotoxic
effects of exogenous CO involve cytochrome c oxidase inhibition and
defects on mitochondrial metabolism and energy production. This has
been demonstrated in isolated mitochondria from human muscle by the
direct analysis of the activity of respiratory chain complexes [25].
Likewise in HEK293 cells, it was also demonstrated that HO-1 over-
expression and endogenous CO production also moderately decreased
cellular respiration along with partial inhibition of cytochrome c oxi-
dase [26]. In fact, CO binds to cytochrome c oxidase and slows down
the rate of electron transport, leading to electrons accumulation, in
particular at complex III. Thus, the lifetime of the ubisemiquinone state
of coenzyme Q is prolonged, increasing the propensity to reduce O2 into
superoxide (O2−), which is enzymatically converted to other ROS, in
particular hydrogen peroxide (H2O2) that can then act as signaling
molecules [21,27]. Likewise, CO-mediated inhibition of cytochrome c
oxidase can be partial or transitory, which enables low levels of ROS
production without further damaging mitochondria [28] (Fig. 1).
Zuckerbraun and colleagues have demonstrated that CO generates
mitochondrial ROS and promotes anti-inflammatory effects in macro-
phages [27]. Low concentrations of exogenous CO partially inhibited
cytochrome c activity, generating mitochondrial ROS, which in turn
limited LPS-induced inflammation by promoting p38 MAPK phos-
phorylation and decreasing TNF-α levels. The presence of antimycin A
or in respiration deficiency ρ° cells CO's anti-inflammatory effect is re-
verted, indicating its dependency on mitochondrial ROS signaling [27].
Likewise, CO is anti-inflammatory in macrophages via PPARβγ SU-
MOlation and p38 activation, whose upstream effectors are mitochon-
drial ROS. CO-induced generation of mitochondrial ROS depends on a
mild uncoupling effect via targeting the uncoupling protein 2 (UCP2),
since whenever Ucp2 gene is knocked out, CO anti-inflammatory ca-
pacity is lost along with a decrease on mitochondrial ROS production
[29]. In airway smooth muscle cells (ASMC), CO modulates cell pro-
liferation by generating mitochondrial ROS [30]. Finally, in primary
culture of cerebellar neurons, CO gas prevented apoptosis mediated by
excitotoxicity and by oxidative stress in a ROS dependent manner [31].
Co-treatment with the anti-oxidant butyl-hydroxytoluene and CO re-
verted the anti-apoptotic role of this gasotransmitter [31]. In summary,
low concentrations of exogenous CO or endogenous CO target mi-
tochondria, generating low amounts of ROS, which act as signaling
molecules (Fig. 1). Nevertheless, one cannot disregard that high CO
levels inhibit mitochondrial respiratory chain and generate toxic
amounts of ROS and oxidative stress. Subcellular localization of CO can
also regulate ROS production, for instance Taillé and colleagues have
demonstrated that CORM-2 treatment inhibited the activity of NAD(P)
H oxidase cytochrome b558, which decreases plasmatic membrane ROS
production, while there is an increase on mitochondrial ROS generation
by targeting cytochrome c oxidase [30]. Therefore, exogenous CO
Fig. 1. CO promotes mitochondrial ROS
generation. CO can bind and inhibit cyto-
chrome c oxidase, which accumulates elec-
trons at the mitochondrial electron trans-
port chain. Accumulation of electrons
enhances the probability of O2 reduction
into anion superoxide, which is quickly
converted into other ROS, namely hydrogen
peroxide. Because low amounts of CO par-
tially and transitorily binds to cytochrome c
oxidase low levels of ROS are generated that
act as cell signaling molecules.
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(delivered by CORMs) and endogenously produced CO may present
different subcellular localizations, with potential different effects on
ROS generation and signaling.
5. CO stimulates mitochondrial biogenesis
The consequence of CO targeting mitochondria is not limited to ROS
production, since this gasotransmitter also activates mitochondrial
biogenesis (Fig. 2). CO has been demonstrated to promote cytoprotec-
tion via activation of mitochondrial biogenesis in several different cel-
lular models with distinct damage triggering factors. In 2007, it was
found by Suliman and colleagues that CO stimulates mitochondrial
biogenesis in cardiomyocytes using in vivo and cell culture models
[32,33]. Transient elevations of intracellular CO levels increased
number of mitochondrial DNA and the protein content of complexes
I–V. Likewise, CO upregulated the expression of nuclear respiratory
factor-1 and -2 (Nrf-1, Nrf-2), peroxisome proliferator-activated re-
ceptor gamma co-activator-1α (PGC-1α) and mitochondrial transcrip-
tion factor (TFAM), which are key transcription factors controlling
mitochondrial biogenesis. Moreover, the CO-induced mitochondrial
biogenesis was dependent on hydrogen peroxide generation and in-
dependent on nitric oxide synthase activation [32]. Still, CO stimula-
tion of mitochondrial biogenesis was cardioprotective by limiting
doxorubicin-induced apoptosis [33]. Likewise, in a mice sepsis model
induced by peritonitis, CORM-3 treatment improved cardiac mi-
tochondrial function via stimulation of mitochondrial biogenesis in a
PGC-1α and ROS dependent manner [34]. Interestingly, HO-1 over-
expression and CO production activated the mitochondrial biogenesis
Nrf2 transcription factor, along with upregulation of the anti-in-
flammatory proteins IL-10 and the IL-1 receptor antagonist (IL-1Ra)
[35]. These data couples mitochondrial biogenesis with the CO anti-
inflammatory role in LPS-induced inflammation cellular model and in
mice challenged with Escherichia coli sepsis [35]. Furthermore, activa-
tion of mitochondrial biogenesis by HO-1 rescued mice from lethal
Staphylococcus aureus sepsis, via redox-regulated NF-E2–related factor-2
signaling [36]. In another model, HO-1 activity, along with CO pro-
duction, protects macrophages against endoplasmic reticulum stress via
mitochondrial biogenesis and in a protein kinase RNA-like endoplasmic
reticulum kinase (PERK)-dependent manner [37]. The naturally
occurring flavonoid Quercetin presents several beneficial biological
effects including promotion of mitochondrial biogenesis in a HO-1/CO
axis dependent manner in HepG2 cells [38]. Finally, CO gas protected
astrocytes against apoptosis by increasing mitochondrial population in
a Bcl-2 dependent manner [28]. Likewise, Kim and colleagues demon-
strated that CORM-2 activation of L-type Ca2+ channel mediates PGC-
1α/ERRα axis, which leads to mitochondrial biogenesis and main-
tenance of astrocyte function in astrocytes [39]. The same authors have
recently demonstrated that CORM-2 increases HIF-1α stabilization,
which is necessary for ERRα-mediated mitochondrial biogenesis [40].
This data can be controversial since HIF-1α stabilization is usually as-
sociated with an increase of glucose uptake and glycolytic metabolism
[41]. Semenza and colleagues have demonstrated in renal carcinoma
cells that HIF-1 negatively regulates mitochondrial biogenesis by pre-
venting C-MYC activity, which in turn reduces PGC-1β expression and
mitochondrial biogenesis [42]. This controversy can be partially ex-
plained by the different PGC-1 family members: PGC-1α and PGC-1β
[41]. Moreover, the same researchers also shown that under hypoxia,
HIF-1 modulates the expression of cytochrome c oxidase subunit 4
(COX4), by decreasing COX4-1 and increasing COX4-2, which promotes
COX activity, oxygen consumption and ATP production [43]. Thus the
same group demonstrated two different effects of HIF on glycolysis and
mitochondrial metabolism. Of note, Semenza group work has been
developed in cancer cell lines, while Kim's research has been done in
primary cultures of astrocytes, which may also influence the potential
different responses to HIF stabilization. Taken all together, in different
cell types and models, CO-induced mitochondrial biogenesis is essential
for its cytoprotective and anti-inflammatory roles (Fig. 2). Data are
summarized in Table 1.
6. CO and mitochondrial quality control
CO-mediated mitochondrial function also implicates modulation of
mitochondrial quality control. Mitochondrial quality control can be
defined as the balance between mitochondrial biogenesis and elimina-
tion of dysfunctional mitochondria via autophagy (mitophagy) [44,45].
In hepatocytes, CO activates protein kinase R (PKR)-like en-
doplasmic reticulum (ER) kinase (PERK), which in turn promotes nu-
clear translocation of transcription factor EB (TFEB) [46]. TFEB
Fig. 2. CO stimulates mitochondrial biogenesis.
CO exposure upregulates the expression of peroxi-
some proliferator-activated receptor gamma co-acti-
vator-1α (PGC-1α) and the nuclear respiratory
factor-1 and 2 (Nrf-1/2), which regulate the expres-
sion of nuclear encoding mitochondrial proteins.
PGC-1α interaction with Nrf-1/2 also coordinates the
upregulation of the mitochondrial transcription
factor (TFAM) that modulates transcription of mi-
tochondrial DNA. These factors are all involved in
CO-induced mitochondrial biogenesis.
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Table 1
CO and mitochondrial function.
Biological function: mitochondrial biogenesis
Experimental Model Assessment of mitochondrial biogenesis Biological outcome of CO Ref.
Cardiomyocytes (in vivo and cell culture) Increased content of mtDNA, mitochondrial proteins
(complexes I-IV)
Upregulation of Nrf1, Nrf2, TFAM and PGC-1α
Mitochondrial biogenesis in a ROS dependent manner [32]
In vivo mouse model for doxorubicin-induced
heart failure
Increased content of mtDNA, mitochondrial proteins
Upregulation of TFAM
Cardioprotection against doxorubicin-induced apoptosis via
mitochondrial biogenesis
[33]
In mice peritonitis-induced sepsis model Increased content of mtDNA
Upregulation of PGC-1α
Cardioprotection in sepsis context via mitochondrial
biogenesis
Reduces mortality
[34]
In mice Escherichia coli-induced sepsis Upregulation of Nrf2 Anti-inflammatory effect
Upregulation of IL-10 and IL-1Ra
[35]
In mice Staphylococcus aureus-induced sepsis Increased content of mtDNA, mitochondrial protein
(citrate synthase)
Upregulation of Nrf1, Nrf2, TFAM and PGC-1α
Reduction of mortality
Anti-inflammatory effect via upregulation of NF-E2–related
factor-2
[36]
Macrophages Increased content of mtDNA
Upregulation of Nrf1, TFAM and PGC-1α
Cytoprotection against thapsigargin-induced endoplasmic
reticulum stress
[37]
Hepatocytes (HepG2 cell line) Increased content of mtDNA, mitochondrial proteins
(complex IV)
Upregulation of Nrf1, TFAM and PGC-1α
Mitochondrial biogenesis promoted by Quercetin via CO
production
[38]
Primary culture of mouse astrocytes Increased content of mtDNA Cytoprotection against oxidative stress-induced apoptosis [28]
Primary culture of mouse astrocytes Increased content of mitochondrial proteins
(cytochrome c and cytochrome c oxidase)
Upregulation of PGC-1α
Cytoprotection/maintenance of astrocytic function [39]
Mouse ischemic brain injury model Upregulation of PGC-1α Improvement of astrocytic mitochondrial function [40]
Biological function: mitochondrial metabolism
Experimental Model Effects and Mechanisms of CO Biological outcome of CO Ref.
Diabetic kidney Upregulation of carnitine, citrate, deoxynucleotide,
dicarboxylate and ADP/ATP carriers
Increase of cytochrome c oxidase activity
Improvement of mitochondrial metabolism
Reversion of diabetes-induced lower mitochondrial transport
carriers
[49]
Isolated mouse liver mitochondria Inhibition of mitochondria membrane depolarization
induced by oxidative stress
Increased activity of cytochrome c oxidase
Anti-apoptotic effect [50]
Primary culture of astrocytes
Isolated mouse cortex non-synaptic
mitochondria
Increased specific activity of cytochrome c oxidase and
O2 consumption
Increased content of mtDNA
Bcl-2 dependent mechanism
Oxidative metabolism improvement
Increased ATP production
[28]
Primary culture of astrocytes
Isolated rat cortex non-synaptic
mitochondria
Inhibition of mitochondria membrane depolarization
induced by oxidative stress
ROS dependent mechanism
Protein glutathionylation signaling
Anti-apoptotic effect [51]
Primary culture of astrocytes and neurons Increased ATP production
Purinergic signaling
Astrocytic-neuronal communication for preventing neuronal
cell death induced by oxidative stress
[53]
Microglia challenged with LPS Increased ATP production
Decreased glycolytic metabolism
Maintenance of ATP production
Anti-neuroinflammatory effect [54]
Human teratocarcinoma NT2 cell line Enhanced mitochondrial population
Higher expression of pyruvate and lactate
dehydrogenase
Higher levels of tricarboxylic acid cycle metabolites
Improvement of neuronal differentiation [58]
Embryonic stem cell differentiation into
cardiomyocytes
Improvement of mitochondrial function
Increased mtDNA
Differentiation and maturation of cardiomyocytes [59]
Human prostate cancer cells Shifts from glycolytic into oxidative metabolism Anti-Warburg effect
Sensitizes cancer cells to respond to chemotherapy by cell
metabolism regulation
Promotes apoptosis
[60]
Biological function: mitochondrial uncoupling & CO
Experimental Model Effects and Mechanisms of CO Biological outcome of CO Ref.
Isolated rat renal mitochondria (in vivo
treatment)
Decreased levels of state 3 respiration
Decreased respiratory control index
Uncoupling mitochondrial respiration [65]
Isolated rat heart mitochondria Increased levels of state 2 respiration
Modulation by adenine nucleotide translocator (ANT)
and uncoupling proteins (UCP)
Uncoupling mitochondrial respiration [66]
Isolated rat heart mitochondria Decreased hydrogen peroxide production at complex I
level
Dependent on phosphate carrier and dicarboxylate
carrier
Uncoupling mitochondrial respiration [67]
Human endothelial EA.hy926 cells Increased oxygen consumption
Increased proton leak
Increased state 2 respiration
Uncoupling mitochondrial respiration [68]
(continued on next page)
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translocation is involved in lysosomal and mitochondrial biogenesis. In
TFEB deficient cells, CO failed to promote Parkin translocation into
mitochondria and to induce mitophagy. Likewise, knockdown expres-
sion of TFEB also decrease expression of lysosomal genes (Lamp1, ca-
thepsin B and TPP1), along with a decrease on mitochondrial DNA,
mitochondrial biogenesis markers (PGC-1α, Nrf1 and TFAM) and mi-
tochondrial proteins, such as COX II, COX IV and cytochrome c [46]. In
summary, TFEB emerges as a key regulator of CO-dependent cytopro-
tection in hepatocytes, being associated with modulation of mitophagy
and mitochondrial biogenesis [46].
The term mitochondrial quality control can be also applied for the
maintenance of mitochondrial function via regulation of fusion/fission
processes, which promote dynamic changes in mitochondrial mor-
phology in response to environment, nutritional conditions and po-
tential stress. In fact, CO modulation of mitochondrial quality control
also involves fusion and fission processes. Actually, increased expres-
sion of HO-1, caused by hemin exposure, protects astroglial C6 cell line
against manganese (Mn2+) induced oxidative stress and cell death via
regulation of mitochondrial quality control [47]. Hemin treatment
limited mitochondrial fragmentation and mitophagy and improved
mitochondrial interconnectivity, along with a decrease on hydrogen
peroxide and anion superoxide levels [47]. Nevertheless, it is not clear
which are the downstream pathways related to mitochondrial fusion/
fission and mitophagy, and which are the involved HO-1 products. In
addition, Hull and colleagues have described how mice overexpressing
HO-1 are protected against DOX-induced cardiotoxicity via modulation
of mitochondrial quality control [48]. Overexpression of HO-1 led to
mitochondrial biogenesis activation assessed by increased expression of
TFAM, PGC-1α and Nrf1, and presence of mitochondrial DNA. More-
over, HO-1 overexpression also decreased fission and increased fusion
levels, measured by morphology and expression of mitochondrial fis-
sion 1 (Fis1) and mitofusin 1 and 2 (Mfn1 and Mfn2). Finally, HO-1
improved basal levels of mitophagy immediately after DOX treatment,
while at 14 days later HO-1 prevented mitophagy progression since it is
much higher at WT animals [48].
In summary, a tight-controlled crosstalk between the mitochondrial
processes: biogenesis, fusion, fission and mitophagy is necessary to
promote cellular homeostasis. The exact role of CO in this tight control
needs further clarification, in particular how CO regulates mitophagy,
which are the molecular players and its crosstalk to biogenesis and
fission/fusion processes.
7. CO modulation of mitochondrial metabolism
The direct effect of CO on mitochondrial metabolism has also been
described, namely the activity of mitochondrial respiratory chain
complexes, oxygen consumption or mitochondrial membrane permea-
bilization.
It is well established that in diabetes, the kidney presents lower
levels of mitochondrial transport carriers. This effect is reverted by CO
exposure. Overexpression of HO-1 or its up-regulation by treatment
with cobalt protoporphyrin (CoPP) leaded to a robust increase in car-
nitine, citrate, deoxynucleotide, dicarboxylate and ADP/ATP carriers,
along with an increase on cytochrome c oxidase activity [49], sug-
gesting an improvement on mitochondrial metabolism. In isolated liver
mitochondria, low concentrations of CO gas (CO-saturated PBS solu-
tions) improved ADP/ATP translocase activity and inhibited mi-
tochondrial membrane permeabilization (MMP), which is a key step in
apoptosis control. CO protection against MMP was assessed by
inhibition of mitochondrial swelling, mitochondrial depolarization,
inner membrane permeabilization and cytochrome c release, as well as
by modulation of cytochrome c oxidase activity [50]. CO treatment
limited MMP in a ROS dependent manner, since whenever ROS are
scavenged by β-carotene CO did not inhibit MMP. In addition, CO
transiently decreased specific activity of cytochrome c oxidase during
the first 10 min of exposition and at 30 min there was an increase of its
activity [50]. This CO-induced two-step response in cytochrome c ac-
tivity was also observed in non-synaptic mitochondria isolated from rat
cortex [28]. In this study, CO prevented astrocytic cell death by re-
inforcing mitochondrial metabolism, namely CO increased ATP pro-
duction and oxygen consumption. CO pushed the glycolysis/oxidative
phosphorylation (OXPHOS) balance towards OXPHOS and increased
specific activity of cytochrome c oxidase, along with an enhancement of
mitochondrial population [28]. Likewise, in astrocytic primary culture
and enriched non-synaptic mitochondria from rat cortex, low con-
centrations of CO gas also prevented MMP. In fact, CO improved ADP/
ATP mitochondrial inner membrane translocation and maintained mi-
tochondrial metabolism in a ROS dependent manner via mitochondrial
protein glutathionylation signaling [51]. Therefore, one may speculate
that CO generates small amounts of ROS by partially and transitorily
inhibiting cytochrome c oxidase. These ROS act as signaling molecules
that, in turn, improve mitochondrial metabolism and function
[28,50,51]; including cytochrome c oxidase activity [28,50]. Never-
theless, the molecular mechanisms underlying this dual effect of CO on
cytochrome c oxidase activity is not yet clearly disclosed. The hypoth-
esis about CO modulation of mitochondrial metabolism in a ROS de-
pendent manner is deeper discussed in Refs. [10,22,52]. Finally, in the
brain context, CO-increased astrocytic production of ATP and pur-
inergic signaling is also important for glia cell-neuron communication
and the maintenance of neuronal function and survival in response to
oxidative stress [53].
Inflammatory response in macrophages and microglia is accom-
panied by cellular metabolic changes, favoring glycolysis over oxidative
phosphorylation. In microglia, CO presents anti-neuroinflammatory
properties, which are associated with CO-induced cell metabolism
modulation [54]. Actually, low concentrations of CORM-401 decreased
glycolytic metabolism, maintaining ATP production and mitochondrial
respiration in microglia challenged with lipopolysaccharide (LPS) [54].
The CO-increased respiration levels is associated with an uncoupling
activity. While higher concentrations of CORM-401 or prolonged per-
iods of CORM-401 exposure also inhibited mitochondrial respiration
and decreased ATP production, suggesting a biphasic effect of CO on
microglial metabolism.
During neuronal differentiation there is a metabolic switch: from
mainly glycolytic metabolism (cell proliferation phase) into oxidative
metabolism and increased mitochondrial population (cell differentia-
tion phase) [55–57]. Likewise, CORM-A1 supplementation of differ-
entiation medium containing retinoic acid improved neuronal differ-
entiation of human embryonic teratocarcinoma NT2 cell line by
favoring mitochondrial metabolism [58]. CORM-A1 supplementation
increased neuronal yield along with enhanced mitochondrial popula-
tion, higher expression of pyruvate and lactate dehydrogenase and in-
creased the percentage of 13C incorporation from 13C-glucose into the
tricarboxylic acid cycle metabolites. Whenever NT2 cells were differ-
entiated under 5% of oxygen levels, which promotes glycolytic meta-
bolism, there was a reversion on CO-improved neuronal differentiation
[58]. Likewise, in another cell type, HO-1/CO axis is essential for stem
cell differentiation into mature and functional cardiomyocytes in a
Table 1 (continued)
Microglia challenged with LPS Higher levels of oxygen consumption and ATP
generation
Dependent on mild uncoupling and ROS production
Mild uncoupling effect
Anti-neuroinflammatory effect
[54]
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manner that is dependent on mitochondrial biogenesis [59].
Cancer cells are known to present Warburg effect, which consists in
having mainly glycolytic metabolism, even in the presence of normal
levels of oxygen. In human prostate cancer cells, HO-1 is mainly present
in the nucleus with low enzymatic activity and correlates with worse
clinical outcomes. Overexpression of HO-1 or exogenous administration
of CO improved prostate cancer cell response to chemotherapy in-
creasing apoptosis levels and mitotic catastrophe. Likewise, CO limited
growth of human prostate cancer xenografts. This sensitization is con-
sequence of an increased mitochondrial metabolism induced by CO. CO
increased oxygen consumption and pushed cell metabolism towards
mitochondria, leading to cell metabolic exhaustion [60] and an anti-
Warburg effect mode of action. Furthermore, CO act in a ROS depen-
dent manner, since whenever ROS are depleted using a cocktail of pe-
gylated catalase and superoxide dismutase, CO loses its effect on mi-
tochondrial metabolism [60].
In summary, CO emerges as a molecule able to reinforce oxidative
mitochondrial metabolism in several different models, kidney brain,
heart, cancer cells leading to homeostasis, cell survival, cell differ-
entiation and anti-tumorigenesis effects (Fig. 3, Table 1).
8. CO decreases glycolysis
Along and in accordance with CO-mediated effect on oxidative
metabolism, this gasotransmitter also decreases glycolysis in three
distinct models (Fig. 3). In a model of ischemic myocardium, CO gas
inhalation during 200 min and reaching 5% of COHb levels, improved
metabolic conditions by decreasing glycolysis. Levels of lactate in the
myocardium were 50% lower in pig pre-conditioned with CO gas than
in control pigs. Accordingly, CO-treated animals presented higher glu-
cose levels in myocardium than control animals [61]. In a research
work about breast cancer cell adhesion and transmigration across lung
endothelial cells, CORM-401 was found to decrease transmigration by
cell metabolism modulation [62]. CORM-401 differently controls cell
metabolism: in lung endothelial cells CO decreased glycolytic metabo-
lism (assessed by extracellular acidification rate) and activated mi-
tochondrial respiration (assessed via oxygen consumption rate). While
in breast cancer cells CO decreased both mitochondrial respiration and
glycolysis [62]. Cell adhesion and transmigration are highly bioener-
getic demanding cellular processes, being cell metabolism a promising
target for therapy. Finally, in EA.hy926 endothelial cell line CORM-401
treatment also shifts metabolism from glycolysis to oxidative
phosphorylation for ATP production. This effect is accompanied by a
slight mitochondrial depolarization and mild uncoupling affect; which
in turn activates mitochondrial respiration via mitochondrial Ca2+
signaling [63]. Moreover, CORM-401 accelerates mitochondrial NADH
consumption and increases mitochondrial Ca2+ content, which is in
accordance with the fact that Ca2+ activates pyruvate dehydrogenase
(and other hydrogenases) to feed NADH into electron transport chain,
in particular complexes I and II [63]. Nevertheless, in obese mice fed
with high fat diet, oral administration of CORM-401 reduces body
weight and accelerates glucose metabolism in adipocytes by improving
glycolysis [64]. Therefore CO action on metabolism might depend on
tissue type and on pathophysiological conditions. One can speculate
that CO pushes the biological system to an homeostatic status. For in-
stance, in tumor context and cancer cell lines, CO accelerates oxidative
phosphorylation pushing glycolysis down [62,63], in obesity models
CO improves glucose homeostasis [64] or in ischemic conditions CO
optimizes the use of oxygen [61]. Data and references are summarized
in Table 2. Finally, it can also be considered that CO-induced mi-
tochondrial uncoupling might increase mitochondrial respiration as a
compensatory effect, and this is further discussed and explored in the
next section.
9. CO promotes a mild uncoupling effect
In apparent controversy, hemin-activation of HO-1 or treatment
with CORMs (CORM-2, CORM-3 and CORM-A1) decreased state 3
oxygen consumption in isolated mitochondria [65]. State 3 represents
oxygen consumption for oxidative phosphorylation that is associated
with ATP production. Other studies using isolated mitochondria also
point to a mild uncoupling effect of CO. In isolated mitochondria from
rat hearts, low concentrations of CORM-3 promoted an augmentation of
state 2 respiration (oxygen consumption in the absence of ADP,
meaning an increase on oxygen consumption uncoupled of mitochon-
drial potential and ATP production [66], while CORM-3 decreases state
3 respiration. This CO-induced mild uncoupling effect is mediated by
adenine nucleotide translocator (ANT) and uncoupling proteins (UCP),
since their pharmacological inhibition attenuated the CO effect on state
2 respiration [66]. Guanosine 5′-diphosphate (GDP) is general inhibitor
for all UCP family proteins, nevertheless UCP2 and UCP3 are both ex-
pressed in cardiac mitochondria. Furthermore, CORM-3-mediated un-
coupling effect is also associated with modulation of mitochondrial ROS
generation since CORM-3 decreases hydrogen peroxidase production at
Fig. 3. Main cellular metabolic pathways
modulated by CO: mitochondrial meta-
bolism, glycolysis and pentose phos-
phate pathway. Low levels of CO enhance
TCA, improve mitochondrial OXPHOS, in-
crease oxygen consumption and production
of ATP. Accordingly, in most of the tested
models (cell type and pathophysiological
conditions) CO decreases glycolysis. Finally
CO modulates redox processes: ROS appear
as signaling molecules for CO mode of ac-
tion and one of the cytoprotective proper-
ties of CO is anti-oxidant. Thus it is not
surprising that CO also stimulates PPP, a
critical pathway responsible to maintaining
the reducing capacity of the cell, as well as
the cellular nucleotides pool.
C. Figueiredo-Pereira, et al. Redox Biology 32 (2020) 101470
6
complex I level. In addition, this uncoupling effect of CORM-3 in iso-
lated mitochondria was also found to be dependent on phosphate car-
rier [67]. Inhibition of phosphate carrier with N-ethylmaleimide re-
verted CORM-3 effect on reducing mitochondrial potential. Likewise,
higher levels of mitochondrial phosphate were found following treat-
ment with CORM-3, along with mitochondrial swelling [67]. One could
speculate that since these effects were found in isolated mitochondria, a
cell-free system, could not be physiologically representative. Never-
theless, in intact in human endothelial EA.hy926 cells, CORM-401 in-
creased oxygen consumption rate simultaneously with an increase of
proton leak and decrease of mitochondrial reserve capacity, indicating
an uncoupling effect. This effect is dependent on the activation of mi-
tochondrial large-conductance calcium-regulated potassium channel
(mitoBKCa) [68]. Furthermore, low concentrations of CORM-401 are
anti-inflammatory via cell metabolism modulation in microglia [54]. In
this system, LPS-triggered inflammation promoted lower levels of
oxygen consumption, mitochondrial function and cellular ATP gen-
eration, while CORM-401 reverted all these effects. Still, CORM-401
promoted a mild uncoupling outcome without affecting cellular ATP
concentration, but decreasing mitochondrial membrane potential and
generation of ROS [54]. In conclusion, one can speculate that CO-
mediated mild and transitory uncoupling (Fig. 4) promotes mitochon-
drial homeostasis and anti-oxidant effect, which may in turn maintain
mitochondrial function and cellular metabolic status. In summary, CO-
induced mild uncoupling effect improves mitochondrial function via a
compensatory mechanism and ROS signaling, these data are summar-
ized in Table 1.
10. CO stimulates pentose phosphate pathway (PPP)
Mitochondria are the main source of cellular ROS generation under
physiological and pathological conditions. Moreover, reduced glu-
tathione (GSH) is the major anti-oxidant component of the cell, and its
recycling depends on NADPH as source of electrons. NADPH is mostly
generated at the pentose phosphate pathway (PPP). Thus, it is not
surprising that CO may also direct or indirectly modulate PPP. In fact,
the first evidence of CO regulation o PPP was demonstrated in 2014 by
two different groups and in different biological systems. CO-treatment
of whole blood increased levels of reduced GSH in the cytosol of red
blood cells. CO promoted stimulation of PPP, and whenever PPP was
inhibited by 2-deoxyglucose, reduced, GSH levels are partially de-
creased [69]. Nevertheless, other mechanisms in red blood cells were
also found to be involved in CO-increased GSH levels. CO promoted
deglutathionylation of hemoglobin at Cys93 and Cys112, which is a
significant source of reduced GSH. Finally, CO also increased glu-
tathione reductase activity without promoting glycolysis [69]. The axis
HO-1/CO protects cancer cells against oxidative stress, in particular in
leukemia. Yamamoto and colleagues have found that CO promotes a
shift from glycolysis to PPP, supplying NADPH to reduce glutathione
and limit oxidative stress [70]. CO inhibited the heme containing en-
zyme cystathionine β-synthase (CBS) that, in turn, reduced methylation
of PFKFB3, which decreases its activity and fructose 2,6-biphosphate
(F-2,6-BP) production. Since F-2,6-BP is an allosteric activator of the
rate limiting enzyme of glycolysis, phosphofructokinase-1, there was an
acceleration of PPP with the consequent increased cellular resistance to
oxidative damage by presenting higher levels of reduced glutathione
[70].
In the human endothelial cell line EA.hy926, CORM-401 promoted
NO production and triggered Ca2+ release from the endoplasmic re-
ticulum, increasing Ca2+ intracellular levels. Inhibition of NO synthase
by L-NAME limited NO production and prevents Ca2+ signaling, in-
dicating that CO increase of Ca2+ is dependent on NO generation.
Furthermore, CO-induced NO production was prevented by 6-amino-
nicotinamide, which is an inhibitor of PPP. PPP is the major enzymatic
source of NADPH, a molecule required for NO synthase [71]. Therefore,
reinforcement of PPP by CORM-401 is also important for NADPH
Table 2
CO and glycolysis.
Biological function: Glycolysis
Experimental Model Effects and Mechanisms of CO Biological outcome of CO Ref.
In vivo pig model of ischemic myocardium Lower levels of lactate and higher levels of glucose in response to
ischemia
Metabolic cardioprotection in ischemic context [61]
Lung endothelial cells
Breast cancer cells
Decreased glycolytic metabolism and increased mitochondrial
respiration in endothelial cells
Decreased glycolytic and mitochondrial metabolism in cancer cells
Decreased cancer cell transmigration
Modulation of cell metabolism in cancer and
endothelial cells
[62]
EA.hy926 endothelial cell line Acceleration of NADH consumption
Increased mitochondrial calcium levels, activating mitochondrial
respiration
Dependent on mild mitochondrial uncoupling effect
Metabolic shift from glycolytic to oxidative [63]
In vivo obesity mouse model
High fat diet
Adipocytes
Decreased mitochondrial ATP production
Increased glycolysis
Dependent on mitochondrial uncoupling effect
Metabolic shift from oxidative to glycolytic [64]
Fig. 4. CO promotes mild uncoupling effect in
mitochondria. CO-induced mild uncoupling is de-
pendent on ANT and UCP and this event is associated
with anti-inflammatory role of CO. It is speculated
that a small leakage of protons into mitochondrial
matrix may generate ROS and accelerate respiratory
chain for maintaining mitochondrial membrane po-
tential, both events shall improve mitochondrial
function and metabolism.
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production, required in nitric oxide (NO) synthesis in endothelial cells
[71]. It is well established that during neuronal differentiation, there is
a switch from glycolytic to oxidative mitochondrial metabolism
[72,73]. Thus, neurons are mostly oxidative and must present an ef-
fective anti-oxidant defense, being GSH the major cellular non-enzy-
matic anti-oxidant factor. In a recent paper, Almeida and colleagues
used human neuroblastoma SH-SY5Y cells as models for neuronal dif-
ferentiation and exposed them to CORM-A1. CORM-A1 improved
neuronal differentiation by increasing the final yield of neurons, by
reinforcing PPP activity and increasing cellular GSH/GSSG ratio [74].
CO treatment enhanced protein expression and activity of glucose 6-
phosphate dehydrogenase (G6PD), which is the rate-limiting enzyme of
PPP. Whenever G6PD was knocked down there was a reversion of CO-
induced improvement of neuronal differentiation, while pharmacolo-
gical inhibition of GSH synthesis did not change neuronal differentia-
tion. Likewise, CO increased the reduced and oxidized glutathione
(GSH/GSSG) without changing total pool of GSH, which is in ac-
cordance with CO-induced activation of PPP [74]. In conclusion, CO
emerges as a modulator of PPP, but much data is still needed for deeply
and precisely describe the underlying molecular mechanisms (Fig. 3,
Table 3).
11. CO, obesity and diabetes diseases
Modulation of metabolism by CO is not limited to cellular meta-
bolism, but this gasotransmitter also plays a role in metabolic diseases
(diabetes and obesity), which is discussed herein.
In intact mouse islet, exogenous CO gas improved glucose-stimu-
lated insulin secretion in a cGMP signaling dependent manner [75].
Likewise, CO stimulated the activities of the lysosomal/vacuolar en-
zymes: acid glucan-1,4-α-glucosidase and acid α-glucosidase (acid α-
glucoside hydrolases), which are involved in glycogen hydrolyzation
[75].
In an obesity mouse model based on high fat diet, chronic and
preventive intraperitoneal (IP) administration of CORM-A1 reverted
obesity by decreasing body and epididymal fat weight and reduced
fasted blood glucose and insulin in a food intake independent manner
[76]. Furthermore, in epididymal fat tissue, CORM-A1 treatment in-
creased expression levels of uncoupling protein-1 (UCP-1), PGC-1α and
Nrf-1, which are considered markers of mitochondrial heat production
and mitochondrial biogenesis. These facts are in accordance with the
higher levels of oxygen consumption and heat production of CORM-A1
treated mice [77]. Moreover, chronic treatment with CORM-A1 can
reverse established dietary-induced obesity, hyperglycemia, and insulin
resistance [77]. Oral administration of CORM-401 also decreased body
weight and improved insulin sensitivity and glucose tolerance in high
fat diet mouse model for diabetes [64]. CORM-401 reverted the in-
crease on cellular size of epididymal white adipocytes following high
fat diet and reduced macrophage infiltration in white fat tissue, de-
creasing the levels of pro-inflammatory factors (IL-6, IL-1β and HO-1).
In contrast to the previous works, the described underlying molecular
mechanism is based on reinforcement of glycolytic metabolism for in-
creasing ATP intracellular levels in white adipocytes [64]. In fact,
CORM-401 did not revert the reduction of Pgc-1α mRNA expression in
white adipocyte tissue. Nevertheless, in brown adipocyte tissue, CO
restored the levels of Pgc-1α and Ucp-1 mRNA [64], which might in-
dicate an increase on mitochondrial population and/or function. In
summary the effects of CO described by Braud's and Hosick's teams are
similar but the underlying metabolic mechanisms in white adipocytes
are different.
In the same high fat diet model of diabetes, fibroblast growth factor
21 (FGF-21) is necessary for CO gas to reduce obesity, glucose tolerance
and improve insulin sensitivity following high fat diet [78]. The CO-
induced increased expression of FGF-21 in liver and primary hepato-
cytes is dependent on mitochondrial ROS generation. In hepatocytes,
CO increased protein levels of complex III and IV, as well as of Nrf-1,
TFAM and PGC-1α, which are associated with increased mitochondrial
biogenesis, and accordingly enhances oxygen consumption. Likewise,
CO also increased mitochondrial population in white fat tissue, which
converts into beige tissue by switching cell metabolism. All these mi-
tochondrial events are dependent on FGF-21 presence [78]. In sum-
mary, CO improves mitochondrial metabolism in hepatocytes and
converts white adipocytes into beige ones, in order to prevent obesity
and diabetes type 2.
In a model of metabolic syndrome, based on mice fed with high fat
diet, CO (CORM-3 administration) improved cardiac function by mod-
ulation of mitochondrial population quality [79]. High fat diet for 12
weeks decreased intrinsic contractile function in left ventricle. This
cardiac dysfunction was accompanied by an alteration in mitochondrial
morphology and function, including: (i) an increase of mitochondrial
volume and number, along with higher expression levels of the mi-
tochondrial fusion genes Mfn2 and OPA1 and mitochondrial biogenesis
gene PGC-1α; and (ii) a decrease of oxygen consumption and mi-
tochondrial membrane potential [79]. These mitochondrial events were
reverted by two CORM-3 IP injections. Furthermore, high fat diet does
not modulate autophagy, while CORM-3 treatment with high fat diet
promoted autophagy assessed by LC3I/II ratio [79]. In an apparent
contradiction, Lancel and colleagues showed that CO reverted the high
fat diet-induced mitochondrial biogenesis and fusion, while most of
data in the literature claim the cardioprotection ability of CO is de-
pendent on mitochondrial biogenesis.
The regulatory role of CO in obesity and diabetes is an emerging
research filed and more data are necessary to disclose its mechanisms
and the targeted cells and tissues.
12. Conclusions
The fact that CO targets mitochondria, in particular cytochrome c
oxidase, originates several consequences: (i) generation of ROS for
downstream signaling, (ii) alterations in oxygen consumption implying
uncoupling effects and/or improvement of mitochondrial respiration
and ATP production, (iii) regulation of mitochondrial quality control,
Table 3
CO and pentose phosphate pathway.
Biological function: Pentose Phosphate Pathway
Experimental Model Effects and Mechanisms of CO Biological outcome of CO Ref.
Red blood cells Stimulation of pentose phosphate pathway (PPP)
2-deoxyglucose reverts PPP stimulation
Increased reduced glutathione levels [69]
Leukemia cancer cells Limitation of glycolysis favoring PPP
Dependent on inhibition of cystathionine β-synthase and on inhibition of
phosphofructokinase-1 (rate limiting glycolytic enzyme)
Increased cancer cell resistance against
oxidative stress
Higher reduced glutathione levels
[70]
EA.hy926 endothelial cell line Promotion of Ca2+ release from the endoplasmic reticulum
Acceleration of PPP and in consequence NADPH production
Increased NO production [71]
Human neuroblastoma SH-SY5Y cell
line
Increased expression and activity of glucose 6-phosphate dehydrogenase
Higher levels of reduced glutathione
Improvement of neuronal differentiation [74]
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including mitochondrial biogenesis, mitophagy and fusion/fission.
Likewise, related to cell metabolism and redox response, CO also ap-
pears to modulate glycolysis and pentose phosphate pathway. Because
these are vital cellular process, endogenous CO production or exo-
genous CO treatment have great impact on cellular function at distinct
cells and tissues, namely: liver, heart, brain, and also in metabolic
diseases, such as diabetes and obesity.
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